A detailed history of Israel Englander (Millennium Management LLC) transactions in Eli Lilly & CO stock. As of the latest transaction made, Millennium Management LLC holds 184,700 shares of LLY stock, worth $147 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
184,700
Previous 532,038 65.28%
Holding current value
$147 Million
Previous $482 Million 66.03%
% of portfolio
0.08%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $354 Million - $440 Million
458,171 Added 86.12%
990,209 $877 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $212 Million - $266 Million
-292,285 Reduced 35.46%
532,038 $482 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $41.2 Million - $55.2 Million
69,615 Added 9.22%
824,323 $641 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $33.6 Million - $39.6 Million
-63,980 Reduced 7.81%
754,708 $440 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $286 Million - $382 Million
815,226 Added 23547.83%
818,688 $384 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $22.9 Million - $26.9 Million
-73,828 Reduced 95.52%
3,462 $1.19 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $84 Million - $97.9 Million
-261,319 Reduced 77.17%
77,290 $28.3 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $174 Million - $199 Million
-588,486 Reduced 63.48%
338,609 $109 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $147 Million - $173 Million
527,177 Added 131.82%
927,095 $301 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $35.2 Million - $43.8 Million
-150,187 Reduced 27.3%
399,918 $115 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $36.5 Million - $45.3 Million
162,429 Added 41.9%
550,105 $152 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $57 Million - $70.1 Million
257,044 Added 196.77%
387,676 $89.6 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $3.52 Million - $4.56 Million
-19,505 Reduced 12.99%
130,632 $30 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $172 Million - $223 Million
-1,048,442 Reduced 87.47%
150,137 $28 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $19.4 Million - $25.6 Million
148,398 Added 14.13%
1,198,579 $202 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $122 Million - $141 Million
834,266 Added 386.39%
1,050,181 $155 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $26.8 Million - $32.2 Million
196,369 Added 1004.65%
215,915 $35.4 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $31.8 Million - $39.3 Million
-267,023 Reduced 93.18%
19,546 $2.71 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $22.4 Million - $27.7 Million
209,412 Added 271.41%
286,569 $37.7 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $15.6 Million - $16.9 Million
-145,835 Reduced 65.4%
77,157 $8.63 Million
Q2 2019

Aug 15, 2019

BUY
$110.79 - $129.32 $23.7 Million - $27.7 Million
214,279 Added 2459.3%
222,992 $24.7 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $67.1 Million - $78.3 Million
-605,517 Reduced 98.58%
8,713 $750,000
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $98.6 Million - $116 Million
-885,389 Reduced 59.04%
614,230 $79.7 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $73.9 Million - $82.7 Million
697,472 Added 86.95%
1,499,619 $174 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $936,475 - $1.17 Million
10,907 Added 1.38%
802,147 $86.1 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $21.4 Million - $24.5 Million
-282,255 Reduced 26.29%
791,240 $67.5 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $15 Million - $17.7 Million
202,294 Added 23.22%
1,073,495 $83.1 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $56.1 Million - $60.2 Million
684,795 Added 367.37%
871,201 $73.6 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $14.4 Million - $15.9 Million
186,406
186,406 $15.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.